β-Eudesmol has potential anti-angiogenic and anti-tumour activities, it inhibits angiogenesis by suppressing CREB activation in the growth factor signaling pathway, and is an inhibitor of tumour growth.
Molecular Formula
C15H26O
Form
White crystal or powder
Purity
>98%, determined by HPLC.
Identity
Confirmed by NMR and MS.
Applications
β-Eudesmol can be used for anti-angiogenic and anti-tumour activity experiments, etc.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.